Fenwick Represents Evidation Health in $45 Million Series D Financing

Fenwick represented Evidation Health, a health data analytics platform provider, in its $45 million Series D financing. B Capital Group led the round, which includes new investors McKesson Ventures and Section 32 as well as existing investors Revelation Partners, Rethink Impact and SV Health Investors.

This round of funding will help Evidation power the expansion of its privacy-first, direct-to-person research platform, Achievement, to include virtual health. The company will use this new capital to build upon its existing evidence generation capabilities to offer real-time insights and digital tools to its network of nearly 4 million individuals. More information can be obtained from the company’s announcement.

The Fenwick transaction team included corporate partner Michael Esquivel, associates Ryan McRobert and Noah Johnson, and law clerk Sarah Hill.